scPharmaceuticals (SCPH) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free SCPH Stock Alerts $4.57 +0.01 (+0.22%) (As of 04/22/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinescPharmaceuticals (NASDAQ:SCPH) Stock Price Down 5.4%marketbeat.com - April 18 at 12:40 AMNovel Biannual Antihypertensive Shows Potential for Combination Therapymsn.com - April 10 at 6:08 PMThose who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 62%finance.yahoo.com - March 27 at 9:26 AMscPharmaceuticals, Inc.: scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Updatefinanznachrichten.de - March 20 at 6:25 PMHC Wainwright Reaffirms Buy Rating for scPharmaceuticals (NASDAQ:SCPH)marketbeat.com - March 18 at 4:34 PMscPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcriptinsidermonkey.com - March 16 at 5:02 PMSCPH Apr 2024 5.000 putfinance.yahoo.com - March 16 at 2:28 AMBuy Rating Affirmed for scPharmaceuticals Amidst Revenue Surge and Solid Financial Footingmarkets.businessinsider.com - March 15 at 4:27 PMQ4 2023 scPharmaceuticals Inc Earnings Callfinance.yahoo.com - March 14 at 3:51 PMAnalysts Have Conflicting Sentiments on These Healthcare Companies: Neurocrine (NBIX), Jazz Pharmaceuticals (JAZZ) and scPharmaceuticals (SCPH)markets.businessinsider.com - March 14 at 10:50 AMStrong Buy Recommendation for scPharmaceuticals on Furoscix’s Successful Launch and Growth Prospectsmarkets.businessinsider.com - March 14 at 10:50 AMscPharmaceuticals Inc (SCPH) Reports Q4 and Full-Year 2023 Financials, Focusing on FUROSCIX Growthfinance.yahoo.com - March 13 at 6:18 PMscPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Updateglobenewswire.com - March 13 at 4:01 PMscPharmaceuticals Q4 2023 Earnings Previewmsn.com - March 12 at 8:33 PMCraig-Hallum Reaffirms Their Buy Rating on scPharmaceuticals (SCPH)markets.businessinsider.com - March 11 at 6:45 PMscPharmaceuticals Inc Registered Shs hosts conference call for investorsmarkets.businessinsider.com - March 9 at 1:38 PMscPharmaceuticals (SCPH) Set to Announce Earnings on Wednesdaymarketbeat.com - March 7 at 1:08 PMscPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024globenewswire.com - March 6 at 4:01 PMscPharmaceuticals to Participate in Two Upcoming Investor Conferencesglobenewswire.com - February 28 at 4:01 PMscPharmaceuticals Stock (NASDAQ:SCPH), Short Interest Reportbenzinga.com - February 21 at 8:00 PMTejara Capital Ltd Invests $722,000 in scPharmaceuticals Inc. (NASDAQ:SCPH)marketbeat.com - February 16 at 12:21 PMEquities Analysts Issue Forecasts for scPharmaceuticals Inc.'s FY2027 Earnings (NASDAQ:SCPH)marketbeat.com - February 7 at 9:09 AMDelveInsight Business Research, LLP: Heart Failure Treatment Drug Market to Accelerate Immensely by 2032, Predicts DelveInsightfinanznachrichten.de - January 15 at 5:47 PMTop 10 stocks with the highest short interest on Wall Streetmsn.com - January 8 at 3:25 PMStrong Buy: scPharmaceuticals’ Furoscix Shows Robust Sales Growth and Solid Financial Healthmarkets.businessinsider.com - January 7 at 5:46 AMBuy Rating for scPharmaceuticals: Furoscix’s Market Traction and Growth Potential Drive Positive Valuationmarkets.businessinsider.com - January 5 at 11:23 PMscPharmaceuticals, Inc.: scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX Revenuefinanznachrichten.de - January 5 at 8:21 AMscPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenuefinance.yahoo.com - January 4 at 8:19 PMPinstripes, SoFi Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Sessionmarkets.businessinsider.com - January 3 at 7:29 AMShort Interest in scPharmaceuticals Inc. (NASDAQ:SCPH) Decreases By 26.1%marketbeat.com - December 30 at 10:39 AMBarclays PLC Sells 67,692 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH)marketbeat.com - December 28 at 4:02 AMVYGR, VSAT and SNBR are among after hour moversmsn.com - December 23 at 8:50 AMscPharmaceuticals Inc SCPHmorningstar.com - December 22 at 1:58 PMscPharmaceuticals Q3 Earnings: Cruising Toward Successseekingalpha.com - November 12 at 9:53 AMscPharmaceuticals’ Growth Indicators and Future Potential: An Analysis of the Buy Rating and Furoscix’s Rising Demandmarkets.businessinsider.com - November 9 at 11:40 PMAnalysts Are Bullish on Top Healthcare Stocks: Kura Oncology (KURA), Steris (STE)markets.businessinsider.com - November 9 at 1:40 PMscPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 9 at 1:40 PMRecap: scPharmaceuticals Q3 Earningsbenzinga.com - November 8 at 5:10 PMscPharmaceuticals GAAP EPS of -$0.41 misses by $0.05, revenue of $3.8M beats by $0.38Mmsn.com - November 8 at 5:10 PMscPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - November 8 at 5:10 PMEarnings Preview: scPharmaceuticalsbenzinga.com - November 7 at 4:04 PMscPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023finance.yahoo.com - November 1 at 8:49 PMAfter big year of funding, Rapport Therapeutics hires a veteran CFObizjournals.com - October 30 at 2:29 PMThose who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 47%finance.yahoo.com - October 19 at 10:24 AMscPharmaceuticals: Furoscix, Charting A Bright Future With FDA's Nod For CKDmsn.com - September 27 at 7:51 AMAnalysts Offer Insights on Healthcare Companies: Henry Schein (HSIC) and scPharmaceuticals (SCPH)markets.businessinsider.com - September 21 at 5:55 PMscPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiativesfinance.yahoo.com - September 19 at 12:27 PMSizing Up scPharmaceuticalsmsn.com - September 13 at 6:49 PMCraig-Hallum Initiates Coverage of scPharmaceuticals (SCPH) with Buy Recommendationmsn.com - September 8 at 3:03 AMscPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 5 at 4:45 PM Get scPharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter. Email Address [Shocking] Elon Musk’s Plan To End Banks (Ad)Leaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030. Click here now to get your copy. SCPH Media Mentions By Week SCPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCPH News Sentiment▼0.590.48▲Average Medical News Sentiment SCPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCPH Articles This Week▼11▲SCPH Articles Average Week Get scPharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Regulus Therapeutics News Renovaro News Inventiva News Skye Bioscience News Adicet Bio News Incannex Healthcare News CervoMed News Veru News Trevi Therapeutics News Gossamer Bio News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCPH) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding scPharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
